With Prolia Rival In The Bag, China’s Luye Takes Aim At Xgeva Biosimilar
With Prolia Rival In The Bag, China’s Luye Takes Aim At Xgeva Biosimilar
Boan Biotech is continuing its ascent in Chinese biosimilars by filing another product with the country’s regulator.
